三個皮匠報告
政策庫
new
付費
搜索

ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗-行業數據

ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗
ZL-1310 預計將持續一線/二線 SCLC 以及其他 DLL3 高表達腫瘤的臨床試驗。ZL-1310針對二線 SCLC 的單藥治療預計 2024年至 2025 年初進入劑量擴展階段，聯合鉑類藥物與阿替利珠單抗治療一線 SCLC預計 2025年進入劑量遞增臨床試驗階段。
行業數據 下載Excel 下載圖片 原圖定位
圖片屬性
圖片格式：PNG 圖片大?。?10KB 圖片尺寸：1735*713
同報告圖片
 / 20
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗_第1頁
5Lul5LiL5piv5qC55o2u5oKo5o+Q5L6b55qE5Zu+54mH55Sf5oiQ55qE5pWw5o2u6KGo5qC877yaCgp8IEluZGljYXRpb24gICAgICAgICAgICAgICAgICAgICAgIHwgRGlzY292ZXJ5ICAgICAgICAgICAgICAgICAgICAgICB8IFByZWNsaW5pY2FsIHwgUGhhc2UgMSAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCBQaGFzZSAyICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCAyTCArIFNDTEMgICAgICAgICAgICAgICAgICAgICAgICB8IFpMLTEzMTAgbW9ub3RoZXJhcHkgICAgICAgICAgICAgfCAgICAgICAgICAgICB8IFlFJzI0L0Vhcmx5IDIwMjU6IERvc2UgZXhwYW5zaW9uL29wdGltaXphdGlvbiAgICB8ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAxTCBTQ0xDICAgICAgICAgICAgICAgICAgICAgICAgICB8IFpMLTEzMTAgKyBwbGF0aW51bSArIGF0ZXpvbGl6dW1hYiB8ICAgICAgICAgICAgIHwgMjAyNTogRG9zZSBlc2NhbGF0aW9uIGluaXRpYXRpb24gICAgICAgICAgICAgICAgfCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgT3RoZXIgRExMMy1leHByZXNzaW5nIHR1bW9ycyAgICAgfCBaTC0xMzEwIG1vbm8vY29tYm8gICAgICAgICAgICAgIHwgICAgICAgICAgICAgfCAyMDI1OiBDbGluaWNhbCB0cmlhbHMgaW4gcGxhbm5pbmcgICAgICAgICAgICAgICB8ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muWGjem8juWMu+iNr+WFrOWRig==
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗_第2頁
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗_第3頁
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗_第4頁
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗_第5頁
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
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗_第6頁
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗_第7頁
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗_第8頁
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗_第9頁
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗_第10頁
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗_第11頁
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗_第12頁
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗_第13頁
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
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗_第14頁
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗_第15頁
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
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗_第16頁
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗_第17頁
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗_第18頁
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
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗_第19頁
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗_第20頁
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
ZL-1310預計將持續一線/二線SCLC以及其他DLL3高表達腫瘤的臨床試驗_第21頁
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
所屬報告： 生物制品行業深度報告：DLL3SCLC高表達明星靶點多款國產新藥未來可期-241230（17頁）.pdf
打包全文圖表

相關數據

最新數據
聯系我們
  • 0731-84720580
  • sgpjbg002
  • 工作日 9:30 - 18:00
關于我們
侵權處理
關于我們

三個皮匠報告專業的行業報告下載站，每日更新，歡迎大家關注！

copyright@2008-2013 長沙景略智創信息技術有限公司版權所有
網站備案/許可證號：湘B2-20190120

客服
商務合作
小程序
服務號
折疊
午夜网日韩中文字幕,日韩Av中文字幕久久,亚洲中文字幕在线一区二区,最新中文字幕在线视频网站